Zim Laboratories share price is ₹108.59 as of 18 Jun, 2026. The stock Zim Laboratories intraday movement has stayed between ₹108.02 and ₹112.00, while on a 52-week basis,Zim Laboratories price 52 week high is ₹127.00 & its 52 week low is ₹59.31.
In terms of trading activity, Zim Laboratories has recorded a volume of 46229 shares, The Zim Laboratories has a market cap of ₹53549037 CR. The stock’s Average Traded Price (ATP) stands at ₹110.43, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 160 @ ₹108.59.
Zim Laboratories operates within a circuit range of ₹105.67 – ₹116.79, with a Value of ₹51.05 L. The Delivery Percentage for the day is 0%. Additionally, Zim Laboratories currently falls under the No framework, and trades with a market lot size of 1.
Zim Laboratories announced the availability of the audio recording for its Q4 & FY26 earnings conference call. Investors can access the recording on the company's official website to review management's discussion on financial performance and outlook.
Zim Laboratories reported Q4 FY26 total operating income of Rs.105.3 cr (down 3.2% YoY) and net profit of Rs.3.7 cr (down 23.4% YoY). Full year FY26 net profit declined 52% YoY to Rs.5.8 cr.
May 19 2026 19:23:11
Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zim Laboratories' wholly-owned European subsidiary, SIA ZIM Laboratories Limited, Latvia, has received Marketing Authorization (MA) for Dabigatran Etexilate capsules (75, 110, 150 mg) in Italy. This approval, granted by AIFA, opens access to the broader EU market for this product, estimated at USD 392.84 million by 2025.
May 19 2026 18:11:36
Zim Laboratories Ltd - 541400 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 19.05.2026
Zim Laboratories board approved Q4 FY26 cons. financial results, reporting revenue of ₹108.66 cr (up 3.2% YoY) and net profit of ₹4.40 cr (up 17.6% YoY). The board also approved FY26 cons. results with net profit of ₹12.17 cr (up 108.4% YoY) and appointed a Cost Auditor for FY27.
The Buying Price of Zim Laboratories share is 108.59 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Zim Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Zim Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Zim Laboratories shares is 99.52. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Zim Laboratories shares is 1.98. Useful to assess the stock's value relative to its book value.
To assess Zim Laboratories’s valuation compare Sector P/E, P/B which are 70.31 & 3.03 with sector averages, along with growth rates and financial metrics.
The Market Cap of Zim Laboratories is 581.49 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Zim Laboratories share price is 127.00 & 59.31. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Zim Laboratories belongs to the Healthcare sector.